Clinical trialNCT02334306CompletedPhase 2Interventional

A Phase 2a, Randomized, Placebo Controlled, Study to Evaluate the Safety and Efficacy of AMG 557/MEDI5872 in Primary Sjögren's Syndrome

SponsorMedImmune LLCEnrollment32Primary Sjögren's Syndrome

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

A Phase 2a study to evaluate the efficacy and safety of AMG 557/MEDI5872 in Primary Sjögren's Syndrome

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

Ghaith Noaiseh, MD
University of Pittsburgh
Principal Investigator
clinicaltrials.gov ↗
Maria Dall'Era, MD
University of California, San Francisco
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

France

Research Site
Brest, France
Research Site
Le Kremlin-Bicêtre, France
Research Site
Lille, France
Research Site
Paris, France
Research Site
Paris, France
Research Site
Strasbourg, France

Sweden

Research Site
Stockholm, Sweden

United Kingdom

Research Site
London, United Kingdom
Research Site
Newcastle upon Tyne, United Kingdom
Research Site
Swindon, United Kingdom

United States

Research Site
San Francisco, California, United States
Research Site
Bethesda, Maryland, United States
Research Site
Pittsburgh, Pennsylvania, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

AMG 557/MEDI5872

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 8 Jun 2015
Primary completion: 16 Jan 2018
Completion: 13 Aug 2018
Last update posted: 19 Mar 2019
Registered enrollment: 32
Registry id: NCT02334306

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.